Biomarker Menu
Biomarker Menu

Explore Our Biomarker Menu

Including 400+ Biomarker Offerings for a Range of Disease States

Return to Biomarker Menu

Biomarker: PARP (D214-cleaved)

Search for Biomarkers

Analyte:

PARP (D214-cleaved)

Platform:

Matrix:

Human Liver Homogenates

Disease State:

Status:

Validated

Required Sample Volume:

25 µL/well

Sensitivity-LLOQ/ULOQ:

LLOQ: 5.00 ug/mL equ of PWCL
ULOQ: 180 ug/mL equ of PWCL

Biological or Clinical Significance:

The Cleaved-PARP-1 (D214) pAb Antibody is a Rabbit Polyclonal antibody to PARP, PPOL, ADPRT, ADPRT1, PARP-1, PARP1, poly (ADP-ribose) polymerase 1, ARTD1. This antibody recognizes Rat, Mouse, Human antigen. The Cleaved-PARP-1 (D214) pAb Antibody has been validated for the following applications: Western Blot.

PARP, a 116 kDa nuclear poly (ADP-ribose) polymerase, appears to be involved in DNA repair in response to environmental stress. This protein can be cleaved by many ICE-like caspases in vitro and is one of the main cleavage targets of caspase-3 in vivo (4,5). In human PARP, the cleavage occurs between Asp214 and Gly215, which separates the PARP amino-terminal DNA binding domain (24 kDa) from the carboxy-terminal catalytic domain (89 kDa) (2,4). PARP helps cells to maintain their viability; cleavage of PARP facilitates cellular disassembly and serves as a marker of cells undergoing apoptosis (6).

References:

Speak to a Scientist

















What would you like to discuss?

With whom will we be speaking?






I consent to receive communications (which may include, phone, email, social, and re-targeting ads) from BioAgilytix. I understand I may proactively manage my preferences or opt-out of communications with BioAgilytix at any time using the unsubscribe link provided in all of BioAgilytix’s email communications and can learn more by reading the privacy policy.

Yes I confirm that I am over the age of 16 and I consent to communications from BioAgilytix.


biomarker services

Services

See how our premier bioanalytical services support all phases of biomarker, immunogenicity, PK, and cell-based assay studies.

Explore our services

case studies

Case Studies

Learn why we’re a trusted partner to 22 of the top 25 global pharma and biotech companies.

Read our case studies